l-carnitine and l-acetylcarnitine supplementation for idiopathic male infertility

Reproduction & Fertility
Jul 2020
Citations:31
Influential Citations:1
Systematic Reviews / Meta-Analyses
84
S2 IconPDF Icon

Enhanced Details

Methods
Randomized controlled trials (parallel-group, no crossover) in adult men aged 18–65 with idiopathic infertility and abnormal semen parameters; infertility duration >1 year.
Intervention
L-carnitine and/or L-acetylcarnitine supplementation; dosage not reported; duration 3–6 months; route of administration not specified.
Results
Carnitine supplementation improved semen quality: total sperm motility increased by MD 10.72% (95% CI 3.94–17.50; n=459; 7 RCTs); progressive motility increased by MD 9.82% (95% CI 2.01–17.62; n=231; 3 RCTs); sperm concentration did not significantly change (MD 0.79 million/mL; 95% CI −0.39 to 1.96; n=279; 4 RCTs). Sperm morphology improved in some studies. Clinical pregnancy rate did not differ significantly (RR 1.03; 95% CI 0.54–1.96; n=301; 5 RCTs); live birth data were not reported. Overall, evidence is low to very low due to high heterogeneity and risk of bias. Natural conception is not clearly improved by carnitine; more high-quality RCTs reporting pregnancy and live births are needed.
Limitations
High heterogeneity among trials (I2 often very high), small sample sizes, risk of bias due to unclear randomization/blinding, varied regimens and durations (LC, LAC, or both), limited pregnancy/live birth data, and reliance on surrogate semen outcomes.

Abstract

Summary Fifteen percent of couples are globally estimated to be infertile, with up to half of these cases attributed to male infertility. Reactive oxidative species (ROS) are known to damage sperm leading to impaired quantity and quality. Although no...